Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03506542Phase 2Completed
Phase 2, randomised, open-label trial in Glaucoma and cataract, sponsored by Medical University of Lublin. Primary endpoint: Intraocular Pressure at 12 months. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03506542.